Ligand Pharmaceuticals Incorporated LGND
295.04 USD -6.67 (-2.21%)
As ofNov 17, 2026, 1:43 PM EST
293.12 Day range 301.96
175.89 52-week range 326.63
- YTD
- +56.05%
- 1 year
- +46.53%
Next earnings
Feb 25, 2027
Expected Feb 25, 2027. Consensus EPS estimate 2.88.
Included in Essentials and up
Sign in to see Estimates and results by quarter
Analyst estimates for the coming quarters next to what the company reported.
Earnings history
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 25, 2027 | Dec 30, 2026 | 2.84 | — | — | — |
| Oct 29, 2026 | Sep 30, 2026 | 2.33 | 2.67 | +0.34 | +14.59% |
| Aug 6, 2026 | Jun 30, 2026 | 2.01 | 2.37 | +0.36 | +17.91% |
| May 14, 2026 | Mar 31, 2026 | 1.84 | 1.63 | -0.21 | -11.41% |
| Feb 26, 2026 | Dec 31, 2025 | 1.46 | 2.02 | +0.56 | +38.36% |
| Nov 6, 2025 | Sep 30, 2025 | 1.97 | 3.09 | +1.12 | +56.85% |
